Comparative Efficacy of Colonoscope Distal Attachment Devices in Increasing Rates of Adenoma Detection: A Network Meta-analysis

医学 结肠镜检查 荟萃分析 随机对照试验 泻药 梅德林 腺瘤 相对风险 置信区间 内科学 外科 结直肠癌 癌症 政治学 法学
作者
Antonio Facciorusso,Valentina Del Prete,Rosario Vincenzo Buccino,Nicola Della Valle,Maurizio Cosimo Nacchiero,Fabio Monica,Renato Cannizzaro,Nicola Muscatiello
出处
期刊:Clinical Gastroenterology and Hepatology [Elsevier BV]
卷期号:16 (8): 1209-1219.e9 被引量:64
标识
DOI:10.1016/j.cgh.2017.11.007
摘要

Background & AimsSeveral add-on devices have been developed to increase rates of colon adenoma detection (ADR). We assessed their overall and comparative efficacy, and estimated absolute magnitude of benefit through a network meta-analysis.MethodsWe searched the PubMed/Medline and Embase database through March 2017 and identified 25 randomized controlled trials (comprising 16,103 patients) that compared the efficacy of add-on devices (cap; Endocuff; Arc Medical Design Ltd, Leeds, UK, and Endorings; Us Endoscopy, Mentor, OH) with each other or with standard colonoscopy. The primary outcome was ADR; secondary outcomes included rate of polyp detection, and rate of and time to cecal intubation. We performed pairwise and network meta-analyses, and appraised quality of evidence using Grading of Recommendations Assessment, Development and Evaluation. We estimated the magnitude of increase in ADR by low-performing endoscopists (baseline ADR, 10%) and high-performing endoscopists (baseline ADR, 40%) with use of these devices.ResultsOverall, distal attachment devices increased ADR compared with standard colonoscopy (relative risk [RR], 1.13; 95% CI, 1.03–1.23; low-quality evidence), with potential absolute increases in ADR to 11.3% for low-performing endoscopists and to 45.2% for high-performing endoscopists. In a comparative evaluation, we found low-quality evidence that Endocuff increases ADR compared with standard colonoscopy (RR, 1.21; 95% CI, 1.03–1.41), with anticipated increases in ADR to 12% for low-performing endoscopists and to 48% for high-performing endoscopists. We found very low quality evidence to support the use of Endorings (RR, 1.70; 95% CI, 0.86–3.36) or caps (RR, 1.07; 95% CI, 0.96–1.19) vs standard colonoscopy for increasing ADR. The benefit of one distal attachment device over another was uncertain due to very low quality evidence.ConclusionsBased on network meta-analysis, we anticipate only modest improvement in ADRs with use of distal attachment devices, especially in low-performing endoscopists. Several add-on devices have been developed to increase rates of colon adenoma detection (ADR). We assessed their overall and comparative efficacy, and estimated absolute magnitude of benefit through a network meta-analysis. We searched the PubMed/Medline and Embase database through March 2017 and identified 25 randomized controlled trials (comprising 16,103 patients) that compared the efficacy of add-on devices (cap; Endocuff; Arc Medical Design Ltd, Leeds, UK, and Endorings; Us Endoscopy, Mentor, OH) with each other or with standard colonoscopy. The primary outcome was ADR; secondary outcomes included rate of polyp detection, and rate of and time to cecal intubation. We performed pairwise and network meta-analyses, and appraised quality of evidence using Grading of Recommendations Assessment, Development and Evaluation. We estimated the magnitude of increase in ADR by low-performing endoscopists (baseline ADR, 10%) and high-performing endoscopists (baseline ADR, 40%) with use of these devices. Overall, distal attachment devices increased ADR compared with standard colonoscopy (relative risk [RR], 1.13; 95% CI, 1.03–1.23; low-quality evidence), with potential absolute increases in ADR to 11.3% for low-performing endoscopists and to 45.2% for high-performing endoscopists. In a comparative evaluation, we found low-quality evidence that Endocuff increases ADR compared with standard colonoscopy (RR, 1.21; 95% CI, 1.03–1.41), with anticipated increases in ADR to 12% for low-performing endoscopists and to 48% for high-performing endoscopists. We found very low quality evidence to support the use of Endorings (RR, 1.70; 95% CI, 0.86–3.36) or caps (RR, 1.07; 95% CI, 0.96–1.19) vs standard colonoscopy for increasing ADR. The benefit of one distal attachment device over another was uncertain due to very low quality evidence. Based on network meta-analysis, we anticipate only modest improvement in ADRs with use of distal attachment devices, especially in low-performing endoscopists.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
alice发布了新的文献求助10
2秒前
huminjie完成签到 ,获得积分10
2秒前
3秒前
Kevin Li完成签到,获得积分10
3秒前
4秒前
6秒前
修梨完成签到,获得积分20
7秒前
Hermione发布了新的文献求助10
8秒前
田様应助cindy采纳,获得10
10秒前
10秒前
大海发布了新的文献求助10
11秒前
量子星尘发布了新的文献求助10
11秒前
篇篇高分完成签到,获得积分10
11秒前
doki完成签到,获得积分10
12秒前
成就鲂发布了新的文献求助30
12秒前
Kenzonvay发布了新的文献求助10
12秒前
稳重的小杨完成签到,获得积分10
13秒前
尔尔完成签到,获得积分10
13秒前
djiwisksk66应助VDC采纳,获得10
14秒前
拓力库海完成签到,获得积分10
15秒前
4Xchua发布了新的文献求助10
16秒前
19秒前
Tigher完成签到,获得积分10
21秒前
jinshijie完成签到 ,获得积分10
21秒前
coollittlemouse完成签到,获得积分10
21秒前
22秒前
23秒前
星辰大海应助Marco_hxkq采纳,获得10
24秒前
24秒前
25秒前
哇咔咔完成签到,获得积分10
25秒前
若鱼关注了科研通微信公众号
25秒前
淡然觅海完成签到 ,获得积分10
26秒前
2024220513发布了新的文献求助10
27秒前
玩命的谷槐完成签到,获得积分10
30秒前
善学以致用应助陈晓真采纳,获得10
32秒前
在水一方应助liuguohua126采纳,获得10
32秒前
扶余山本完成签到,获得积分10
33秒前
Hermione完成签到,获得积分10
33秒前
大海完成签到,获得积分10
34秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
Interpretation of Mass Spectra, Fourth Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3951145
求助须知:如何正确求助?哪些是违规求助? 3496497
关于积分的说明 11082681
捐赠科研通 3226970
什么是DOI,文献DOI怎么找? 1784113
邀请新用户注册赠送积分活动 868202
科研通“疑难数据库(出版商)”最低求助积分说明 801089